Terug
Dagbereik
€ 222,06
€ 227,11
52-Weeksbereik
€ 146,00
€ 271,64
Volume
784.891
50D / 200D Gem.
€ 247,28
/
€ 234,60
Vorige Slotkoers
€ 217,56
Koershistorie
Financiële Trends
Sectorvergelijking
vs Industrials sector mediaan (890 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 23,3 | 14,4 |
| P/B | 7,4 | 1,9 |
| ROE % | 32,4 | 11,4 |
| Net Margin % | 6,0 | 6,5 |
| Rev Growth 5Y % | 7,8 | 8,4 |
| D/E | 1,0 | 0,6 |
Koersdoel Analisten
Hold
€ 273,33
+22.8%
Low: € 220,00
High: € 300,00
Forward K/W
20,0
Forward WPA
€ 11,11
WPA Groei (sch.)
+0,0%
Omzet Sch.
33 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 14,60
€ 14,33 – € 14,89
|
38 B | 2 |
| FY2029 |
€ 14,42
€ 14,15 – € 14,71
|
38 B | 5 |
| FY2028 |
€ 13,73
€ 12,73 – € 15,40
|
37 B | 7 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 |
Brundage William
Chief Financial Officer
|
grant | 12.257 | — | — |
| Mar 12, 2026 |
Winckler Richard
Chief Accounting Officer
|
grant | 819 | — | — |
| Feb 27, 2026 |
Baker Kelly A
Director
|
grant | 1 | € 262,85 | € 263 |
| Feb 26, 2026 |
Baker Kelly A
Director
|
grant | 3 | € 261,37 | € 784 |
| Dec 10, 2025 |
Halligan Catherine Ann
Director
|
grant | 331 | — | — |
| Dec 10, 2025 |
Baker Kelly A
Director
|
grant | 331 | — | — |
| Dec 10, 2025 |
May Brian
Director
|
grant | 323 | — | — |
| Dec 3, 2025 |
Halligan Catherine Ann
Director
|
grant | 15 | — | — |
| Dec 3, 2025 |
May Brian
Director
|
grant | 20 | — | — |
| Dec 3, 2025 |
May Brian
Director
|
other | 278 | € 251,44 | € 69.900 |
| Dec 3, 2025 |
BECKWITT RICHARD
Director
|
grant | 15 | — | — |
| Nov 11, 2025 |
Paisley James A.
See Remarks
|
grant | 2 | — | — |
| Nov 11, 2025 |
Paisley James A.
See Remarks
|
other | 1 | € 246,10 | € 246 |
| Nov 11, 2025 |
Thees William T. Jr
Chief Operating Officer
|
grant | 2 | — | — |
| Nov 11, 2025 |
Thees William T. Jr
Chief Operating Officer
|
other | 1 | € 246,10 | € 246 |
| Nov 11, 2025 |
Brundage William
Chief Financial Officer
|
grant | 5 | — | — |
| Nov 11, 2025 |
Brundage William
Chief Financial Officer
|
other | 3 | € 246,10 | € 738 |
| Nov 11, 2025 |
Graham Ian T.
See Remarks
|
grant | 2 | — | — |
| Nov 11, 2025 |
Graham Ian T.
See Remarks
|
other | 1 | € 246,10 | € 246 |
| Nov 10, 2025 |
Halligan Catherine Ann
Director
|
grant | 2 | € 251,73 | € 503 |
Belangrijkste Punten
Revenue grew 7,78% annually over 5 years — modest growth
ROE of 32,42% indicates high profitability
Generating 1,60B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,98%
Cash machine — converts 86,37% of earnings into free cash flow
Capital efficient — spends only 0,99% of revenue on capex
Groei
Revenue Growth (5Y)
7,78%
Revenue (1Y)3,80%
Earnings (1Y)6,97%
FCF Growth (3Y)-16,19%
Kwaliteit
Return on Equity
32,42%
ROIC16,57%
Net Margin6,03%
Op. Margin8,47%
Veiligheid
Debt / Equity
1,02
Current Ratio1,68
Interest Coverage13,72
Waardering
P/E Ratio
23,32
P/B Ratio7,42
EV/EBITDA18,64
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,80% | Revenue Growth (3Y) | 1,71% |
| Earnings Growth (1Y) | 6,97% | Earnings Growth (3Y) | -0,88% |
| Revenue Growth (5Y) | 7,78% | Earnings Growth (5Y) | 5,97% |
| Profitability | |||
| Revenue (TTM) | 30,76B | Net Income (TTM) | 1,86B |
| ROE | 32,42% | ROA | 10,47% |
| Gross Margin | 30,67% | Operating Margin | 8,47% |
| Net Margin | 6,03% | Free Cash Flow (TTM) | 1,60B |
| ROIC | 16,57% | FCF Growth (3Y) | -16,19% |
| Safety | |||
| Debt / Equity | 1,02 | Current Ratio | 1,68 |
| Interest Coverage | 13,72 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 23,32 | P/B Ratio | 7,42 |
| P/S Ratio | 1,41 | PEG Ratio | 2,62 |
| EV/EBITDA | 18,64 | Dividend Yield | 0,01% |
| Market Cap | 43,28B | Enterprise Value | 48,57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 30,76B | 29,64B | 29,73B | 28,57B | 22,79B |
| Net Income | 1,86B | 1,74B | 1,89B | 2,12B | 1,47B |
| EPS (Diluted) | 9,32 | 8,53 | 9,12 | 9,69 | 6,55 |
| Gross Profit | 9,44B | 9,05B | 9,03B | 8,76B | 6,98B |
| Operating Income | 2,61B | 2,65B | 2,66B | 2,82B | 1,95B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 17,73B | 16,57B | 15,99B | 15,66B | 13,71B |
| Total Liabilities | 11,90B | 10,96B | 10,96B | 11,00B | 8,71B |
| Shareholders' Equity | 5,83B | 5,62B | 5,04B | 4,67B | 5,00B |
| Total Debt | 5,97B | 5,52B | 5,26B | 5,13B | 3,60B |
| Cash & Equivalents | 674,00M | 571,00M | 669,00M | 771,00M | 1,34B |
| Current Assets | 10,15B | 9,41B | 9,08B | 9,55B | 8,13B |
| Current Liabilities | 6,03B | 5,22B | 5,43B | 5,80B | 4,74B |